CA 125 (Ovaria CA) ECLIA
Starts at ₱ 1,900
The CA 125 (Ovarian CA) ECLIA test is a blood test that measures the level of the CA 125 protein, which can be elevated in various conditions, including ovarian cancer. Using ElectroChemiluminescence Immunoassay (ECLIA) technology, this test offers sensitive and accurate results. Elevated CA 125 levels may suggest the presence of ovarian cancer but can also be linked to other conditions such as endometriosis or pelvic inflammatory disease.
While the CA 125 test is not a definitive diagnostic tool, it is valuable for monitoring treatment progress in ovarian cancer patients, particularly those undergoing chemotherapy or other targeted therapies, as well as for evaluating symptoms indicative of ovarian abnormalities. This test may also be recommended for individuals with a strong family history of ovarian cancer or those carrying inherited genes that increase their risk, particularly for early detection. The scheduling of this test often depends on individual risk factors, but it is commonly utilized during and after cancer treatment to assess cancer status.
Participating Providers
Tests Included
CA 125 (Ovaria CA) ECLIA
Test Requirements
How to Claim
FREE Hati Health Concierge Service
Hassle-Free Testing with Hati Health
Easy Appointment Booking
Clear & Fixed Pricing
Curated Plans For Your Needs
Related Products
Related Categories
More About This Product
Find best CA 125 (Ovarian CA) ECLIA price in Philippines. The CA 125 (Ovarian CA) ECLIA test is a crucial blood test that measures the CA 125 protein levels, which can be elevated in various conditions, most notably ovarian cancer. Utilizing leading-edge ElectroChemiluminescence Immunoassay (ECLIA) technology, this test ensures sensitive and accurate results, making it a vital part of women's health assessments. Elevated CA 125 levels can indicate ovarian cancer, but can also be linked to other health issues such as endometriosis, pelvic inflammatory disease, or even ovarian cysts.
This blood test is particularly important for monitoring treatment progress in ovarian cancer patients, especially during chemotherapy or other targeted therapies, and is beneficial for evaluating symptoms of ovarian abnormalities like abdominal pain or abnormal bleeding. For those with a family history of ovarian cancer or inherited genetic risks, this test plays a key role in early detection. Regular health assessments that include this test can significantly aid in identifying risk factors and managing symptoms related to ovarian health. Ultimately, this test serves not just as a diagnostic tool but as an essential aspect of general wellness for women.